Literature DB >> 29789870

Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate-possible role of low activity ABC and SLC drug transporters.

L Bielen1,2, I Kralj3, Ela Ćurčić4, M Vodanović2, A Boban2, N Božina1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29789870     DOI： 10.1007/s00228-018-2485-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  14 in total

1.  Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis.

Authors:  Kalliopi P Spyridopoulou; Niki L Dimou; Stavros J Hamodrakas; Pantelis G Bagos
Journal:  Pharmacogenet Genomics       Date:  2012-02       Impact factor: 2.089

2.  Pharmacokinetic interaction between methotrexate and piperacillin/tazobactam resulting in prolonged toxic concentrations of methotrexate.

Authors:  R Zarychanski; K Wlodarczyk; R Ariano; E Bow
Journal:  J Antimicrob Chemother       Date:  2006-05-22       Impact factor: 5.790

3.  Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.

Authors:  Susanne Radtke; Oliver Zolk; Bertold Renner; Marios Paulides; Martin Zimmermann; Anja Möricke; Martin Stanulla; Martin Schrappe; Thorsten Langer
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

4.  Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.

Authors:  Li Li; Sagar Agarwal; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2013-01-07       Impact factor: 3.922

5.  Crystalluria and ciprofloxacin, influence of urinary pH and hydration.

Authors:  S B Thorsteinsson; T Bergan; S Oddsdottir; R Rohwedder; R Holm
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

6.  Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.

Authors:  Lin Yang; Xin Hu; Luhang Xu
Journal:  Tumour Biol       Date:  2012-04-20

7.  Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.

Authors:  R Santucci; D Levêque; A Lescoute; V Kemmel; R Herbrecht
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

8.  Interaction between methotrexate and ciprofloxacin.

Authors:  Jean-Hugues Dalle; Anne Auvrignon; Gilles Vassal; Guy Leverger
Journal:  J Pediatr Hematol Oncol       Date:  2002-05       Impact factor: 1.289

9.  Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.

Authors:  Sujatha Suthandiram; Gin-Gin Gan; Shamsul Mohd Zain; Ping-Chong Bee; Lay-Hoong Lian; Kian-Meng Chang; Tee-Chuan Ong; Zahurin Mohamed
Journal:  Pharmacogenomics       Date:  2014-08       Impact factor: 2.533

10.  Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.

Authors:  David J Reeves; Elizabeth S Moore; Devon Bascom; Brandon Rensing
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335
View more
  1 in total

1.  Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report.

Authors:  You-Lin Shao; Chun-Ming Ma; Jian-Ming Wu; Feng-Cai Guo; Suo-Cai Zhang
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.